Cargando…
Streptococcal IdeS: therapeutic potential for Guillain–Barré syndrome
Plasma exchange and intravenous immunoglobulin are effective in treating Guillain–Barré syndrome (GBS) probably because the former removes IgG autoantibodies and complement and the latter inhibits complement activation subsequent to the autoantibody binding to peripheral nerve antigens. IgG degradin...
Autores principales: | Takahashi, Ryo, Yuki, Nobuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508529/ https://www.ncbi.nlm.nih.gov/pubmed/26194472 http://dx.doi.org/10.1038/srep10809 |
Ejemplares similares
-
Guillain–Barré syndrome and anti-ganglioside antibodies: a clinician-scientist’s journey
por: YUKI, Nobuhiro
Publicado: (2012) -
Action mechanism of corticosteroids to aggravate Guillain-Barré syndrome
por: Wang, Yu-Zhong, et al.
Publicado: (2015) -
Guillain–Barré syndrome
por: Mirian, Ario, et al.
Publicado: (2021) -
Guillain-Barré Syndrome Animal Model: The First Proof of Molecular Mimicry in Human Autoimmune Disorder
por: Shahrizaila, Nortina, et al.
Publicado: (2011) -
Visual Evoked Potentials in Guillain-Barré Syndrome
por: Güngör, Levent, et al.
Publicado: (2011)